Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...
Scientists in search of a smallpox cure hope they'll find one already on the shelf. Their strategy: Sift through the hundreds of potential virus medicines developed by drug companies to see if any ...
13don MSN
SIGA outlines continued TPOXX global expansion and expects EMA smallpox decision in March 2026
Q4 2025 Management View CEO Diem Nguyen noted a continued focus on supporting governments globally in preparedness for biological threats, especially smallpox, with SIGA serving "as the leading ...
On Dec. 9, 1979 — 45 years ago Monday — a commission of doctors working with the World Health Organization declared that smallpox had been eradicated from the face of the Earth. The disease, which ...
Tecovirimat is approved for smallpox treatment under the Food and Drug Administration Animal Rule on the basis of efficacy in nonhuman primate models of mpox (previously known as monkeypox). However, ...
SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine says that action is needed to enhance U.S. readiness for smallpox and related diseases, as well as to ...
On May 8, 1980, forty-five years ago, the World Health Organization, a part of the United Nations, announced that officials had eradicated smallpox from the world’s population. The last case occurred ...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections In the fiscal year 2025, we have achieved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results